Mainstream orthodox medicine considers acquired immune deficiency syndrome (AIDS) to be a disease of the immune system that is caused by a human immunodeficiency virus (HIV) transmitted through sexual or blood contact.
Rated 2.3 / 5 (How Ratings Work)
Possible to probable range of efficacy of cannabis for treatment of hiv/aids.
Based on 20 Studies from 2005 - 2017
Study Name, Description & Year
Rating
Δ9-Tetrahydrocannabinol Suppresses Secretion Of IFNα By Plasmacytoid Dendritic Cells From Healthy And HIV-Infected Individuals
Laboratory Study — 2017
Confirmed Marijuana Use And Lymphocyte Count In Black People Living With HIV
A review of individual case files. — 2017
Targeting Cannabinoid Signaling In The Immune System: “High”-ly Exciting Questions, Possibilities, And Challenges
Review — 2017
No Significant Effect Of Cannabis Use On The Count And Percentage Of Circulating CD4 T-cells In HIV-HCV Co-infected Patients (ANRS CO13-HEPAVIH French Cohort)
Human cohort trial conducted on 955 patients co-infected with HIV and hepatitis C virus. — 2016
Modulation Of HIVGP120 Antigen-Specific Immune Responses In Vivo By Δ9-Tetrahydrocannabinol
Animal study (mice) — 2015
Modulation Of Gut-Specific Mechanisms By Chronic Δ9-Tetrahydrocannabinol Administration In Male Rhesus Macaques Infected With Simian Immunodeficiency Virus: A Systems Biology Analysis
Animal study (Male Rhesus Macaques Monkey) — 2014
Chronic Administration Of Δ9-Tetrahydrocannabinol Induces Intestinal Anti-Inflammatory MicroRNA Expression During Acute Simian Immunodeficiency Virus Infection Of Rhesus Macaques
Animal study (monkey) — 2014
Cannabinoid Inhibits HIV-1 Tat-stimulated Adhesion Of Human Monocyte-like Cells To Extracellular Matrix Proteins.
Laboratory Study — 2014
Delta-9-tetrahydrocannabinol Treatment During Human Monocyte Differentiation Reduces Macrophage Susceptibility To HIV-1 Infection
Laboratory Study — 2014
Endocannabinoids Affect Innate Immunity Of Muller Glia During HIV-1 Tat Cytotoxicity
Laboratory Study — 2014
The Medical Use Of Cannabis For Reducing Morbidity And Mortality In Patients With HIV/AIDS
7 randomized controlled studies conducted on patients with HIV/AIDS — 2013
Attenuation Of HIV-1 Replication In Macrophages By Cannabinoid Receptor 2 Agonists
Laboratory Study — 2013
Marijuana Smoking Does Not Accelerate Progression Of Liver Disease In HIV-hepatitis C Coinfection: A Longitudinal Cohort Analysis
Data were analyzed for 690 HCV polymerase chain reaction positive (PCR-positive) individuals without significant fibrosis or end-stage liver disease (ESLD) at baseline. — 2013
2-Arachidonoyl-glycerol- And Arachidonic Acid-stimulated Neutrophils Release Antimicrobial Effectors Against E. Coli, S. Aureus, HSV-1, And RSV.
Laboratory Study — 2013
A Pilot Study Of The Effects Of Cannabis On Appetite Hormones In HIV-infected Adult Men
A double blind placebo-controlled study conducted on 7 patients with HIV — 2011
Cannabinoid Administration Attenuates The Progression Of Simian Immunodeficiency Virus
Animal Study (Monkeys) — 2011
Efficacy And Tolerability Of High-dose Dronabinol Maintenance In HIV-positive Marijuana Smokers: A Controlled Laboratory Study
Double-blind placebo controlled study on 7 patients with HIV — 2010
Immunoregulation Of A CB2 Receptor Agonist In A Murine Model Of NeuroAIDS
Animal study (mice) — 2010
Marijuana Effectiveness As An HIV Self-care Strategy
775 patients living with HIV/AIDS — 2009
Mechanisms Of HIV-1 Inhibition By The Lipid Mediator N-arachidonoyldopamine
Laboratory Study — 2005